Flolan, the brand name for Epoprostenol, was approved by the FDA in 1995 for patients with primary pulmonary hypertension, or PPH .
Primary pulmonary hypertension is an extremely complex lung condition with no known cure. A progressive disease affecting about 100,000 people worldwide, PPH may lead to congestive heart failure and respiratory failure. PPH is most common in women between ages 21 and 40. Doctors are not sure what causes the illness but it has been linked to the recalled appetite suppressant known as Fen-Phen .
Read More about PPH and Diet Drugs
Flolan is a lifetime therapy which requires uninterrupted infusion because of its short effect (3 to 5 minutes). The drug is very expensive, at around $100,000 or more per year and is used only after a positive diagnosis of PPH. Because of the complexity of administering Flolan, patients use special health care services to learn about administering the treatment.
Flolan therapy has been credited with raising the life expectancy of patients with PPH by 3to 5 years or more.
If you or someone you love has been diagnosed with PPH, you may be entitled to compensation
Home / PPH and Diet Drugs / Flolan Treatment / Other PPH Treatments / Your Legal Rights / Hire a PPH Attorney / Refer This Site / News
